Track topics on Twitter Track topics that are important to you
DelveInsight's, Revatio API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Revatio. The report also highlights the patent details of Revatio.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Evaluate the marketing status of Revatio to exploit opportunities for generic Revatio development opportunities
Design effective counterstrategies to gain competitive advantage by identifying the key patent expiry details with respect to Revatio
API intelligence over Revatio and gaining primary intelligence over Active Ingredient manufacturers by country
Make more informed business decisions from insightful and indepth analysis of the Revatio's performance
pulmonary arterial hypertension
Revatio Marketed Drugs Overview
Revatio Market Assessment
Revatio API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
Revatio US DMF
Revatio US Drug Master Files
Revatio Active Substance Master File/ EUDMF
Revatio Generic players
Revatio Patent Expiration
Revatio Patent Exclusivity
Revatio API Manufacturers
Revatio Global Forecasted Sales Figure
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...